AF
AVXL icon

Allworth Financial’s Anavex Life Sciences AVXL Stock Holding History

Allworth Financial’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.03K Buy
1,965
+1,861
+1,789% +$8.06K ﹤0.01% 3847
2025
Q4 		$371 Sell
104
-6,742
-98% -$41.3K ﹤0.01% 4597
2025
Q3 		$60.9K Sell
6,846
-14,516
-68% -$147K ﹤0.01% 1988
2025
Q2 		$197K Buy
21,362
+10,268
+93% +$87.7K ﹤0.01% 1183
2025
Q1 		$105K Sell
11,094
-314
-3% -$2.96K ﹤0.01% 1207
2024
Q4 		$114K Hold
11,408
– – ﹤0.01% 1203
2024
Q3 		$64.8K Hold
11,408
– – ﹤0.01% 1283
2024
Q2 		$62.5K Buy
11,408
+390
+4% +$1.58K ﹤0.01% 1275
2024
Q1 		$56.1K Hold
11,018
– – ﹤0.01% 1258
2023
Q4 		$103K Hold
11,018
– – ﹤0.01% 932
2023
Q3 		$72.2K Hold
11,018
– – ﹤0.01% 994
2023
Q2 		$89.6K Buy
+11,018
New +$94.4K ﹤0.01% 933

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Allworth Financial's AVXL Position: Q1 2026 in Review

Allworth Financial increased its Anavex Life Sciences (AVXL) stake by 1,789% in Q1 2026, buying an estimated $8.06K and bringing the position to 1,965 shares worth $6.03K. The position accounts for ﹤0.01% of the portfolio, ranked #3847.

Allworth Financial first reported a position in AVXL in Q2 2023 and has held it in 12 quarters since. The position peaked at $197K in Q2 2025. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Allworth Financial held 1,965 shares of Anavex Life Sciences worth $6.03K as of Q1 2026.
  • Allworth Financial bought 1,861 Anavex Life Sciences shares in Q1 2026, an estimated $8.06K.
  • Anavex Life Sciences made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #3847 holding.
  • Allworth Financial first reported a position in Anavex Life Sciences in Q2 2023 and has held it in 12 quarters since.
  • Allworth Financial's Anavex Life Sciences position peaked at $197K in Q2 2025.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.